Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis - PubMed (original) (raw)
Review
Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis
Adam Lundqvist et al. Eur J Public Health. 2016 Oct.
Abstract
Background: Breast cancer is the leading cause of female cancer in Europe and is estimated to affect more than one in 10 women. Higher socioeconomic status has been linked to higher incidence but lower case fatality, while the impact on mortality is ambiguous.
Methods: We performed a systematic literature review and meta-analysis on studies on association between socioeconomic status and breast cancer outcomes in Europe, with a focus on effects of confounding factors. Summary relative risks (SRRs) were calculated.
Results: The systematic review included 25 articles of which 8 studied incidence, 10 case fatality and 8 mortality. The meta-analysis showed a significantly increased incidence (SRR 1.25, 1.17-1.32), a significantly decreased case fatality (SRR 0.72, 0.63-0.81) and a significantly increased mortality (SRR 1.16, 1.10-1.23) for women with higher socioeconomic status. The association for incidence became insignificant when reproductive factors were included. Case fatality remained significant after controlling for tumour characteristics, treatment factors, comorbidity and lifestyle factors. Mortality remained significant after controlling for reproductive factors.
Conclusion: Women with higher socioeconomic status show significantly higher breast cancer incidence, which may be explained by reproductive factors, mammography screening, hormone replacement therapy and lifestyle factors. Lower case fatality for women with higher socioeconomic status may be partly explained by differences in tumour characteristics, treatment factors, comorbidity and lifestyle factors. Several factors linked to breast cancer risk and outcome, such as lower screening attendance for women with lower socioeconomic status, are suitable targets for policy intervention aimed at reducing socioeconomic-related inequalities in health outcomes.
© The Author 2016. Published by Oxford University Press on behalf of the European Public Health Association.
Figures
Figure 1
PRISMA flow diagram of the study selection process
Figure 2
Meta-analysis of studies with incidence as outcome in relation to SES. The studies are organised by included covariates. The black squares and horizontal lines correspond to the study-specific relative risks and 95% confidence intervals, while the diamonds represent the pooled relative risk and the 95% confidence interval
Figure 3
Meta-analysis of studies with case fatality as outcome measure in relation to SES. The studies are organised by included covariates. The black squares and horizontal lines correspond to the study-specific relative risks and 95% confidence intervals, while the diamonds represent the pooled relative risk and the 95% confidence interval
Figure 4
Meta-analysis of studies with mortality as outcome measure in relation to SES. The studies are organised by included covariates. The black squares and horizontal lines correspond to the study-specific relative risks and 95% confidence intervals, while the diamonds represent the pooled relative risk and the 95% confidence interval
Similar articles
- Changing patterns of breast cancer incidence and mortality by education level over four decades in Norway, 1971-2009.
Trewin CB, Strand BH, Weedon-Fekjær H, Ursin G. Trewin CB, et al. Eur J Public Health. 2017 Feb 1;27(1):160-166. doi: 10.1093/eurpub/ckw148. Eur J Public Health. 2017. PMID: 28177482 - Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?
Yabroff KR, Gordis L. Yabroff KR, et al. Soc Sci Med. 2003 Dec;57(12):2265-79. doi: 10.1016/s0277-9536(03)00100-x. Soc Sci Med. 2003. PMID: 14572836 - Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Harper S, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):121-31. doi: 10.1158/1055-9965.EPI-08-0679. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124489 - Recent trends in breast cancer incidence and mortality.
Lacey JV Jr, Devesa SS, Brinton LA. Lacey JV Jr, et al. Environ Mol Mutagen. 2002;39(2-3):82-8. doi: 10.1002/em.10062. Environ Mol Mutagen. 2002. PMID: 11921173 Review. - Systematic review about breast cancer incidence in relation to hormone replacement therapy use.
Antoine C, Ameye L, Paesmans M, Rozenberg S. Antoine C, et al. Climacteric. 2014 Apr;17(2):116-32. doi: 10.3109/13697137.2013.829812. Epub 2013 Oct 29. Climacteric. 2014. PMID: 23909434 Review.
Cited by
- Pattern of burden cancer breast and relationshipin to human development index in Iran 2009 to 2019: an observational study based on the Global Burden of Diseases.
Shoorabeh FF, Goodarzi E, Shafeai F, Pordanjani SR, Abbasi M. Shoorabeh FF, et al. BMC Womens Health. 2024 Sep 27;24(1):540. doi: 10.1186/s12905-024-03378-4. BMC Womens Health. 2024. PMID: 39334063 Free PMC article. - Quality of life of women with a screen-detected versus clinically detected breast cancer in the Netherlands: a prospective cohort study.
Irzaldy A, Otten JDM, Kregting LM, van der Molen DRM, Verkooijen HM, van Ravesteyn NT, Heijnsdijk EAM, Doeksen A, van der Pol CC, Evers DJ, Ernst MF, Korfage IJ, de Koning HJ, Broeders MJM. Irzaldy A, et al. Qual Life Res. 2024 Sep 17. doi: 10.1007/s11136-024-03783-0. Online ahead of print. Qual Life Res. 2024. PMID: 39287764 - Educational disparities in cancer incidence, stage, and survival in Oslo.
Al-Rammahy A, Fadum EA, Nilssen Y, Larsen IK, Hem E, Bringedal BH. Al-Rammahy A, et al. Res Health Serv Reg. 2024 Jan 29;3(1):1. doi: 10.1007/s43999-024-00037-x. Res Health Serv Reg. 2024. PMID: 39177868 Free PMC article. - Sociodemographic inequalities in breast cancer screening attendance in Germany following the implementation of an Organized Screening Program: Scoping Review.
Pedrós Barnils N, Härtling V, Singh H, Schüz B. Pedrós Barnils N, et al. BMC Public Health. 2024 Aug 14;24(1):2211. doi: 10.1186/s12889-024-19673-6. BMC Public Health. 2024. PMID: 39143595 Free PMC article. Review. - Non-genetic factors and breast cancer: an umbrella review of meta-analyses.
Yiallourou A, Pantavou K, Markozannes G, Pilavas A, Georgiou A, Hadjikou A, Economou M, Christodoulou N, Letsos K, Khattab E, Kossyva C, Constantinou M, Theodoridou M, Piovani D, Tsilidis KΚ, Bonovas S, Nikolopoulos GK. Yiallourou A, et al. BMC Cancer. 2024 Jul 26;24(1):903. doi: 10.1186/s12885-024-12641-8. BMC Cancer. 2024. PMID: 39061008 Free PMC article.
References
- Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 2006;17:5–19. - PubMed
- Quaglia A, Lillini R, Mamo C, et al. Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit Rev Oncol Hematol 2013;85:266–77. - PubMed
- Roemer JE. Equality of talent. Econom Philosophy 1985;1:151–88.
- Jusot F, Tubeuf S, Trannoy A. Effort or Circumstances: Does the Correlation Matter for Inequality of Opportunity in Health? Chaire sant’e, 2010.
- Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical